SCHEMBL160812

SCHEMBL160812

CCCCCOC/C=C/c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.50
ALOX5 P09917 1/20 0.47
SIGMAR1 Q99720 6/20 0.44
HTR2A P28223 5/20 0.44
HTR2C P28335 5/20 0.44
HTR2B P41595 5/20 0.44
LTA4H P09960 1/20 0.42
DRD2 P14416 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
OPRM1 P35372 1/20 0.41
EGFR P00533 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629036 1.00 IDO1 (0.50) IDO1ALOX5SIGMAR1HTR2AHTR2C
SCHEMBL8945488 0.98 IDO1 (0.49) IDO1ALOX5SIGMAR1HTR2AHTR2C
SCHEMBL27290950 0.98 IDO1 (0.49) IDO1ALOX5SIGMAR1HTR2AHTR2C
SCHEMBL27642617 0.98 IDO1 (0.49) IDO1ALOX5SIGMAR1HTR2AHTR2C
SCHEMBL11780975 0.98 IDO1 (0.49) IDO1ALOX5SIGMAR1HTR2AHTR2C
SCHEMBL14275040 0.98 IDO1 (0.49) IDO1ALOX5SIGMAR1HTR2AHTR2C
SCHEMBL7061575 0.98 IDO1 (0.49) IDO1ALOX5SIGMAR1HTR2AHTR2C
SCHEMBL27290947 0.98 IDO1 (0.49) IDO1ALOX5SIGMAR1HTR2AHTR2C
SCHEMBL12459724 0.95 IDO1 (0.52) IDO1ALOX5SIGMAR1HTR2AHTR2C
SCHEMBL9117410 0.95 IDO1 (0.52) IDO1ALOX5SIGMAR1HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 977 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119959400-A Method for simultaneously detecting 24 main fragrances in cosmetics 湖北省普林标准技术服务有限公司 2025-05-09 CN claimed
CN-115670525-B Reaction solution for screening hypersensitive sensitive muscles 广州市华代生物科技有限公司 2024-11-29 CN claimed
EP-4037642-B1 NOVEL SUN PROTECTIVE AGENT CONTAINING BISMUTH OXYCHLORIDE FOR PROTECTION AGAINST BLUE LIGHT BEIERSDORF AG (DE) 2024-11-06 EP claimed
EP-4037639-B1 BISMUTH OXYCHLORIDE-CONTAINING SUNSCREEN FOR PROTECTION FROM BLUE LIGHT BEIERSDORF AG (DE) 2024-11-06 EP claimed
CN-118203143-A Yulan Tieguanyin flavored electronic cigarette tobacco tar and electronic cigarette 比亚迪精密制造有限公司 2024-06-18 CN claimed
CN-114829004-B Method for preparing Ni-X-based oxide catalyst and application of Ni-X-based oxide catalyst in transfer hydrogenation 中国科学院青岛生物能源与过程研究所 2024-02-27 CN claimed
CN-115466505-B Silicon PU plastic material 邯郸市爱尚体育科技有限公司 2024-01-12 CN claimed
CN-117288858-A Method for detecting sensitized aromatic agent in children cosmetics based on GC-MS/MS 南京海关轻工产品与儿童用品检测中心 2023-12-26 CN claimed
CN-111918636-B Cosmetic product gel containing fruit acid 拜尔斯道夫股份有限公司 2023-07-18 CN claimed
US-20230121157-A1 ANTI-AGING CARE COMPOSITION COMPRISING PERFUMES BASF SE (DE) 2023-04-20 US claimed
EP-1882471-A2 Cosmetic preparation containing folic acid and perfume constituents Beiersdorf AG (DE) 2008-01-30 EP claimed
EP-1697386-B1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GEN ELECTRIC (US) 2007-10-10 EP claimed
EP-1705171-A1 Improved aromachemicals Flexitral, Inc. (US) 2006-09-27 EP claimed
US-20060166857-A1 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes SYMRISE GMBH & CO. KG (DE) 2006-07-27 US claimed
US-20060094640-A1 Aromachemicals FLEXITRAL, INC. 2006-05-04 US claimed
US-20050119156-A1 Aromachemicals FLEXITRAL, INC. 2005-06-02 US claimed
EP-1458666-A1 IMPROVED AROMACHEMICALS Flexitral Inc. (US) 2004-09-22 EP claimed
WO-2003053902-A1 IMPROVED AROMACHEMICALS FLEXITRAL, INC. (US) 2003-07-03 WO claimed
EP-1056739-B1 NOVEL CYCLIC PRO-PERFUMES HAVING MODIFIABLE FRAGRANCE RAW MATERIAL ALCOHOL RELEASE RATE PROCTER & GAMBLE (US) 2003-05-02 EP claimed
US-6500797-B1 Process for preparing β-ketoester fragrance pro-accords from 1,3-dioxan-4,6-diones THE PROCTER & GAMBLE COMPANY 2002-12-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230121157-A1 ANTI-AGING CARE COMPOSITION COMPRISING PERFUMES CUTA, GLA, DPY30 IDO1 1834/4885ALOX5 172/4885SIGMAR1 2452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.